Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Insulin Glargine as Add-on to Metformin (With or Without Sulfonylureas) in Insulin-Naive Patients With Type 2 Diabetes (SUSTAIN 4): A Randomised, Open-Label, Parallel-Group, Multicentre, Multinational, Phase 3a Trial
About 3,000 cases have already been filed, and that number is expected to grow as use of GLP-1 medications expands
Oral NSAIDs such as ibuprofen or naproxen may be appropriate for moderate pain when used at the lowest effective dose for the shortest duration necessary, particularly in patients without cardiovascular disease, kidney disease, or gastrointestinal risk factors
FIGURE 7 Endothelial cell aging is closely associated with the progression of various diseases, potentially exacerbating the senescence of surrounding cells and worsening pathological processes (Xian et al., 2021
injected, essentially all of it reaches circulation
Some individuals may experience no side effects at all, while others may have mild to moderate reactions